{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:30:26Z","timestamp":1792017026445,"version":"4.4.0"},"reference-count":195,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007835","name":"Silesian University of Technology","doi-asserted-by":"publisher","award":["32\/007\/RGJ21\/0034"],"award-info":[{"award-number":["32\/007\/RGJ21\/0034"]}],"id":[{"id":"10.13039\/501100007835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.drup.2021.100794","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T20:53:28Z","timestamp":1638996808000},"page":"100794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":237,"special_numbering":"C","title":["An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment"],"prefix":"10.1016","volume":"59","author":[{"given":"Sylwester","family":"Dro\u017cd\u017cal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Rosik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacper","family":"Lechowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Machaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Szostak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Przybyci\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh","family":"Lorzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kotfis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Ghavami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek J.","family":"\u0141os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"January","key":"10.1016\/j.drup.2021.100794_bib0005","article-title":"Effectiveness and safety of Niclosamaide as add-on therapy to the standard of care measures in COVID-19 management: randomized controlled clinical trial","author":"Abdulamir","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.drup.2021.100794_bib0010","article-title":"Measures in COVID-19 Management\u202f: randomized controlled clinical trial","author":"Abdulamir","year":"2021","journal-title":"medrxiv.org"},{"key":"10.1016\/j.drup.2021.100794_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2020.e00968","article-title":"Renal artery thrombosis in COVID-19","volume":"22","author":"Acharya","year":"2020","journal-title":"IDCases"},{"issue":"4","key":"10.1016\/j.drup.2021.100794_bib0020","doi-asserted-by":"crossref","first-page":"102186","DOI":"10.1016\/j.dsx.2021.102186","article-title":"Ivermectin and mortality in patients with COVID-19: a systematic review, meta-analysis, and meta-regression of randomized controlled trials","volume":"15","author":"AFMZ","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"issue":"12","key":"10.1016\/j.drup.2021.100794_bib0025","doi-asserted-by":"crossref","first-page":"165968","DOI":"10.1016\/j.bbadis.2020.165968","article-title":"Pleiotropic effects of statins: a focus on cancer","volume":"1866","author":"Ahmadi","year":"2020","journal-title":"Biochim. Biophys. Acta \u2013 Mol. Basis Dis."},{"issue":"12","key":"10.1016\/j.drup.2021.100794_bib0030","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s42399-020-00610-8","article-title":"Dexamethasone for the treatment of coronavirus disease (COVID-19): a review","volume":"2","author":"Ahmed","year":"2020","journal-title":"SN Compr. Clin. Med."},{"key":"10.1016\/j.drup.2021.100794_bib0035","series-title":"Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)","author":"Aleem","year":"2021"},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s13287-020-01963-6","article-title":"Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients","volume":"11","author":"Al-Khawaga","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"2","key":"10.1016\/j.drup.2021.100794_bib0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/febs.14608","article-title":"Endoplasmic reticulum stress signalling\u2013from basic mechanisms to clinical applications","volume":"286","author":"Almanza","year":"2019","journal-title":"FEBS J."},{"issue":"7","key":"10.1016\/j.drup.2021.100794_bib0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/14992027.2020.1776406","article-title":"Does coronavirus affect the audio-vestibular system? A rapid systematic review","volume":"59","author":"Almufarrij","year":"2020","journal-title":"Int. J. Audiol."},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0055","doi-asserted-by":"crossref","first-page":"11974","DOI":"10.1038\/s41598-021-91089-3","article-title":"Hydroxychloroquine plus standard of care compared with standard of care alone in COVID-19: a meta-analysis of randomized controlled trials","volume":"11","author":"Amani","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2021.100794_bib0060","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijid.2020.02.018","article-title":"Discovery and development of safe-in-man broad-spectrum antiviral agents","volume":"93","author":"Andersen","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"July","key":"10.1016\/j.drup.2021.100794_bib0065","first-page":"1","article-title":"Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis","author":"Angamo","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.drup.2021.100794_bib0070","series-title":"Etesevimab and Bamlanivimab. Bethesda (MD)","author":"Anon","year":"2006"},{"issue":"1614","key":"10.1016\/j.drup.2021.100794_bib0075","first-page":"201","article-title":"An EUA for casirivimab and imdevimab for COVID-19","volume":"62","author":"Anon","year":"2020","journal-title":"Med. Lett. Drugs Ther."},{"issue":"1627","key":"10.1016\/j.drup.2021.100794_bib0080","first-page":"97","article-title":"An EUA for sotrovimab for treatment of COVID-19","volume":"63","author":"Anon","year":"2021","journal-title":"Med. Lett. Drugs Ther."},{"issue":"6","key":"10.1016\/j.drup.2021.100794_bib0085","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1007\/s43440-020-00168-1","article-title":"Observational study of people infected with SARS-Cov-2, treated with amantadine","volume":"72","author":"Aranda-Abreu","year":"2020","journal-title":"Pharmacol. Rep."},{"issue":"3","key":"10.1016\/j.drup.2021.100794_bib0090","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/jappl.2001.90.3.795","article-title":"Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat","volume":"90","author":"Armour","year":"2001","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.drup.2021.100794_bib0095","article-title":"Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses","volume":"53","author":"Artese","year":"2020","journal-title":"Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.drup.2021.100794_bib0100","article-title":"Tocilizumab in COVID \u2011 19\u202f: a meta \u2011 analysis, trial sequential analysis, and meta \u2011 regression of randomized \u2011 controlled trials","author":"Arthur","year":"2021","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.drup.2021.100794_bib0105","series-title":"AZD7442 Reduced Risk of Developing Severe COVID-19 or Death in TACKLE Phase III Outpatient Treatment Trial","author":"AstraZeneca","year":"2021"},{"issue":"October 2020","key":"10.1016\/j.drup.2021.100794_bib0110","article-title":"Current views on the potentials of convalescent plasma therapy (CPT) as Coronavirus disease 2019 (COVID\u201019) treatment: a systematic review and meta\u2010analysis based on recent studies and previous respiratory pandemics","author":"Aviani","year":"2021","journal-title":"Rev. Med. Virol."},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0115","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/s41467-021-22446-z","article-title":"Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials","volume":"12","author":"Axfors","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.drup.2021.100794_bib0120","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psym.2020.05.013","article-title":"Neurocovid: pharmacological recommendations for delirium associated with COVID-19","volume":"61","author":"Baller","year":"2020","journal-title":"Psychosomatics"},{"issue":"April","key":"10.1016\/j.drup.2021.100794_bib0125","article-title":"Mortality Benefit of Convalescent Plasma in COVID-19\u202f: A Systematic Review and Meta-Analysis","volume":"8","author":"Bansal","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"issue":"April","key":"10.1016\/j.drup.2021.100794_bib0130","article-title":"Mortality benefit of convalescent plasma in COVID-19: a systematic review and meta-analysis","volume":"8","author":"Bansal","year":"2021","journal-title":"Front. Med."},{"issue":"9","key":"10.1016\/j.drup.2021.100794_bib0135","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41591-021-01449-9","article-title":"Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19\/BNT162b2 vaccination","volume":"27","author":"Barros-Martins","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11658-020-00212-1","article-title":"Unfolded protein response (UPR) integrated signaling networks determine cell fate during hypoxia","volume":"25","author":"Bartoszewska","year":"2020","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.drup.2021.100794_bib0145","first-page":"373","article-title":"Prophylaxis against covid-19: living systematic review and network meta-analysis","author":"Bartoszko","year":"2021","journal-title":"BMJ"},{"issue":"19","key":"10.1016\/j.drup.2021.100794_bib0150","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 \u2014 final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"January","key":"10.1016\/j.drup.2021.100794_bib0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jclinepi.2021.03.020","article-title":"A metaresearch study revealed susceptibility of Covid-19 treatment research to white hat bias: first, do no harm","volume":"136","author":"Bellos","year":"2021","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.drup.2021.100794_bib0160","series-title":"Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19","author":"Bhimraj","year":"2021"},{"issue":"8","key":"10.1016\/j.drup.2021.100794_bib0165","article-title":"Broad-Spectrum, Patient-Adaptable Inhaled Niclosamide-Lysozyme Particles are Efficacious Against Coronaviruses in Lethal Murine Infection Models","volume":"2","author":"Brunaugh","year":"2020","journal-title":"bioRxiv"},{"issue":"10","key":"10.1016\/j.drup.2021.100794_bib0170","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9101125","article-title":"Antibody persistence 6 months post-vaccination with BNT162b2 among health care workers","volume":"9","author":"Campo","year":"2021","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.drup.2021.100794_bib0175","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jinf.2020.06.052","article-title":"Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study","volume":"81","author":"Cantini","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.drup.2021.100794_bib0180","first-page":"1","article-title":"A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1\u20132","key":"10.1016\/j.drup.2021.100794_bib0185","first-page":"41","article-title":"Protective role of ascorbic acid against lipid peroxidation and myocardial injury","volume":"111","author":"Chakrabarty","year":"1992","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.drup.2021.100794_bib0190","series-title":"Diagnosis and Treatment","author":"Chemo brain","year":"2021"},{"issue":"January","key":"10.1016\/j.drup.2021.100794_bib0195","article-title":"Favipiravir versus arbidol for COVID-19: a randomized clinical trial","author":"Chen","year":"2020","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0200","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamainternmed.2020.5503","article-title":"Effect of recombinant human granulocyte colony\u2013stimulating factor for patients with coronavirus disease 2019 (COVID-19) and lymphopenia: a randomized clinical trial","volume":"181","author":"Cheng","year":"2021","journal-title":"JAMA Intern. Med."},{"issue":"11","key":"10.1016\/j.drup.2021.100794_bib0205","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/s41591-021-01527-y","article-title":"Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis","volume":"27","author":"Choi","year":"2021","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.drup.2021.100794_bib0210","doi-asserted-by":"crossref","DOI":"10.1213\/ANE.0000000000005292","article-title":"Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019","volume":"132","author":"Chow","year":"2021","journal-title":"Anesth. Analg."},{"issue":"8","key":"10.1016\/j.drup.2021.100794_bib0215","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s11739-020-02485-y","article-title":"Cause-specific death in hospitalized individuals infected with SARS-CoV-2: more than just acute respiratory failure or thromboembolic events","volume":"15","author":"Cobos-Siles","year":"2020","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.drup.2021.100794_bib0220","series-title":"Coronavirus Disease 2019 (COVID-19) Treatment Guidelines","author":"COVID-19 Treatment Guidelines Panel","year":"2021"},{"key":"10.1016\/j.drup.2021.100794_bib0225","first-page":"374","article-title":"Long covid\u2014mechanisms, risk factors, and management","author":"Crook","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.drup.2021.100794_bib0230","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"issue":"22","key":"10.1016\/j.drup.2021.100794_bib0235","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.2020.22717","article-title":"A proposed framework and timeline of the Spectrum of disease due to SARS-CoV-2 infection","volume":"324","author":"Datta","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.drup.2021.100794_bib0240","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.kint.2021.10.006","article-title":"Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost","volume":"100","author":"Davidovic","year":"2021","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.drup.2021.100794_bib0245","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/ckj\/sfab152","article-title":"Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis","volume":"14","author":"Dekervel","year":"2021","journal-title":"Clin. Kidney J."},{"issue":"November 2020","key":"10.1016\/j.drup.2021.100794_bib0250","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/pds.5234","article-title":"QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir \/ ritonavir\u202f: a systematic review and meta-analysis","author":"Diaz-arocutipa","year":"2021","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0255","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MCG.0000000000001424","article-title":"The prevalence of gastrointestinal symptoms, abnormal liver function, digestive system disease and liver disease in COVID-19 infection: a systematic review and meta-analysis","volume":"55","author":"Dong","year":"2021","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.drup.2021.100794_bib0260","series-title":"Bamlanivimab Plus Etesevimab in Mild or Moderate Covid-19","first-page":"1","author":"Dougan","year":"2021"},{"key":"10.1016\/j.drup.2021.100794_bib0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100719","article-title":"FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy","volume":"53","author":"Dro\u017cd\u017cal","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2021.100794_bib0270","series-title":"Drugvirus","author":"Drugvirus.info","year":"2021"},{"issue":"11","key":"10.1016\/j.drup.2021.100794_bib0275","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11906-016-0688-8","article-title":"Effects of aspirin on endothelial function and hypertension","volume":"18","author":"Dzeshka","year":"2016","journal-title":"Curr. Hypertens. Rep."},{"issue":"9","key":"10.1016\/j.drup.2021.100794_bib0280","article-title":"A randomized clinical trial of the efficacy and safety of interferon \u03b2-1a in treatment of severe COVID-19","volume":"64","author":"Effat","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2021.100794_bib0285","series-title":"COVID-19: EMA Recommends Authorisation of Two Monoclonal Antibody Medicines","author":"European Medicines Agency","year":"2021"},{"issue":"17","key":"10.1016\/j.drup.2021.100794_bib0290","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMc2113468","article-title":"SARS-CoV-2 neutralization with BNT162b2 vaccine dose 3","volume":"385","author":"Falsey","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.drup.2021.100794_bib0295","first-page":"3437","article-title":"Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions","volume":"41","author":"Favas","year":"2020","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.drup.2021.100794_bib0300","first-page":"1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"Vol 1282","author":"Fehr","year":"2015"},{"issue":"4","key":"10.1016\/j.drup.2021.100794_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v13040539","article-title":"Amantadine inhibits sars-cov-2 in vitro","volume":"13","author":"Fink","year":"2021","journal-title":"Viruses"},{"issue":"June","key":"10.1016\/j.drup.2021.100794_bib0310","article-title":"Molnupiravir, an oral antiviral treatment for COVID-19","author":"Fischer","year":"2021","journal-title":"medRxiv Prepr. Serv. Heal. Sci."},{"issue":"10278","key":"10.1016\/j.drup.2021.100794_bib0315","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(21)00370-6","article-title":"SARS-CoV-2 variants and ending the COVID-19 pandemic","volume":"397","author":"Fontanet","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2021.100794_bib0320","series-title":"Fact Sheet for Healthcare Providers: Emergency Use Authorization (EUA) of REGEN-COV (Casirivimab and Imdevimab)","author":"Food and Drug Administration","year":"2020"},{"key":"10.1016\/j.drup.2021.100794_bib0325","series-title":"Fact Sheet for Healthcare Providers: Emergency Use Authorization (EUA) of Bamlanivimab and Etesevimab","author":"Food and Drug Administration","year":"2021"},{"key":"10.1016\/j.drup.2021.100794_bib0330","series-title":"Fact Sheet for Healthcare Providers: Emergency Use Authorization (EUA) of Sotrovimab","author":"Food and Drug Administration","year":"2021"},{"issue":"34","key":"10.1016\/j.drup.2021.100794_bib0335","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.15585\/mmwr.mm7034e4","article-title":"Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection among frontline workers before and during B.1.617.2 (Delta) variant predominance - eight U.S. locations, December 2020-August 2021","volume":"70","author":"Fowlkes","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drup.2021.100794_bib0340","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fmicb.2014.00296","article-title":"Coronavirus infection, ER stress, apoptosis and innate immunity","volume":"5","author":"Fung","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.drup.2021.100794_bib0345","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2019.05.002","article-title":"The ER stress sensor IRE1 and MAP kinase ERK modulate autophagy induction in cells infected with coronavirus infectious bronchitis virus","volume":"533","author":"Fung","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.drup.2021.100794_bib0350","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virusres.2014.09.016","article-title":"Coronavirus-induced ER stress response and its involvement in regulation of coronavirus\u2013host interactions","volume":"194","author":"Fung","year":"2014","journal-title":"Virus Res."},{"issue":"7","key":"10.1016\/j.drup.2021.100794_bib0355","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/v8070184","article-title":"Regulation of stress responses and translational control by coronavirus","volume":"8","author":"Fung","year":"2016","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.drup.2021.100794_bib0360","doi-asserted-by":"crossref","first-page":"7020","DOI":"10.18632\/aging.202557","article-title":"The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study","volume":"13","author":"Gao","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"11","key":"10.1016\/j.drup.2021.100794_bib0365","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/thoraxjnl-2020-215314","article-title":"Respiratory follow-up of patients with COVID-19 pneumonia","volume":"75","author":"George","year":"2020","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.drup.2021.100794_bib0370","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s40121-021-00453-3","article-title":"Randomized prospective open label study shows No impact on clinical outcome of adding losartan to hospitalized COVID-19 patients with mild hypoxemia","volume":"10","author":"Geriak","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.drup.2021.100794_bib0375","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbrc.2020.10.102","article-title":"Evolution patterns of SARS-CoV-2: snapshot on its genome variants","volume":"538","author":"Giovanetti","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"17","key":"10.1016\/j.drup.2021.100794_bib0380","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.jacc.2020.08.059","article-title":"Coronavirus and cardiovascular disease, myocardial injury, and arrhythmia: JACC focus seminar","volume":"76","author":"Giustino","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0385","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/irv.12421","article-title":"Antiviral activity of aspirin against RNA viruses of the respiratory tract-an in vitro study","volume":"11","author":"Glatthaar-Saalm\u00fcller","year":"2017","journal-title":"Influenza Other Resp. Viruses"},{"issue":"October","key":"10.1016\/j.drup.2021.100794_bib0390","article-title":"Waning immunity after the BNT162b2 vaccine in Israel","author":"Goldberg","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.drup.2021.100794_bib0395","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 Days in Patients with Severe Covid-19","volume":"383","author":"Goldman","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2021.100794_bib0400","doi-asserted-by":"crossref","DOI":"10.1177\/20587384211031763","article-title":"The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: meta-analysis","volume":"35","author":"Golpour","year":"2021","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0405","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1208\/s12248-007-9000-9","article-title":"The pharmacokinetics and interactions of ivermectin in humans--a mini-review","volume":"10","author":"Gonz\u00e1lez Canga","year":"2008","journal-title":"AAPS J."},{"issue":"7","key":"10.1016\/j.drup.2021.100794_bib0410","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jama.2021.0202","article-title":"Effect of Bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19","volume":"325","author":"Gottlieb","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.drup.2021.100794_bib0415","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/acn3.51350","article-title":"Persistent neurologic symptoms and cognitive dysfunction in non\u2010hospitalized Covid\u201019 \u201clong haulers.\u201d","volume":"8","author":"Graham","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"6","key":"10.1016\/j.drup.2021.100794_bib0420","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.3390\/nu7064240","article-title":"Modulation of the immune response to respiratory viruses by vitamin D","volume":"7","author":"Greiller","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.drup.2021.100794_bib0425","first-page":"1","article-title":"Effectiveness of COVID-19 vaccines against variants of concern, Canada","author":"Gubbay","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.drup.2021.100794_bib0430","series-title":"Tofacitinib in Patients Hospitalized With Covid-19 Pneumonia","first-page":"1","author":"Gunay","year":"2021"},{"issue":"21","key":"10.1016\/j.drup.2021.100794_bib0435","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa2107934","article-title":"Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab","volume":"385","author":"Gupta","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2021.100794_bib0440","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.3390\/cancers13225721","article-title":"Autophagy: The Potential Link between SARS-CoV-2 and Cancer","volume":"13","author":"Habibzadeh","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2021.100794_bib0445","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pharmthera.2017.10.017","article-title":"Glioblastoma and chemoresistance to alkylating agents: involvement of apoptosis, autophagy, and unfolded protein response","volume":"184","author":"Hombach-Klonisch","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"10223","key":"10.1016\/j.drup.2021.100794_bib0450","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"19","key":"10.1016\/j.drup.2021.100794_bib0455","doi-asserted-by":"crossref","first-page":"e25876","DOI":"10.1097\/MD.0000000000025876","article-title":"High-dose vitamin C intravenous infusion in the treatment of patients with COVID-19","volume":"100","author":"Huang","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.drup.2021.100794_bib0460","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s00330-020-07155-3","article-title":"Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy","volume":"31","author":"Idilman","year":"2021","journal-title":"Eur. Radiol."},{"issue":"12","key":"10.1016\/j.drup.2021.100794_bib0465","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.2021.2747","article-title":"Association of convalescent plasma treatment with clinical outcomes in patients with COVID-19","volume":"325","author":"Janiaud","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.drup.2021.100794_bib0470","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thorax.57.11.939","article-title":"A systematic review of the use of opioids in the management of dyspnoea","volume":"57","author":"Jennings","year":"2002","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0475","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-020-00454-7","article-title":"Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"593","key":"10.1016\/j.drup.2021.100794_bib0480","doi-asserted-by":"crossref","first-page":"eabf1906","DOI":"10.1126\/scitranslmed.abf1906","article-title":"The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates","volume":"13","author":"Jones","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.drup.2021.100794_bib0485","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/s41591-021-01560-x","article-title":"Boosting immunity to COVID-19 vaccines","volume":"27","author":"Juno","year":"2021","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.drup.2021.100794_bib0490","doi-asserted-by":"crossref","first-page":"e1002976","DOI":"10.1371\/journal.ppat.1002976","article-title":"Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects. Lee B, ed","volume":"8","author":"Jurgeit","year":"2012","journal-title":"PLoS Pathog."},{"issue":"11","key":"10.1016\/j.drup.2021.100794_bib0495","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/cmdc.201800100","article-title":"Niclosamide, a Drug with Many (Re)purposes","volume":"13","author":"Kadri","year":"2018","journal-title":"ChemMedChem"},{"issue":"4","key":"10.1016\/j.drup.2021.100794_bib0500","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jacl.2020.06.009","article-title":"Are statins safe in patients with COVID-19?","volume":"14","author":"Karalis DG","year":"2020","journal-title":"J. Clin. Lipidol."},{"issue":"3","key":"10.1016\/j.drup.2021.100794_bib0505","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/cts.13001","article-title":"Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID\u201019 patients: a systematic review and meta\u2010analysis of randomized controlled trials","volume":"14","author":"Kashour","year":"2021","journal-title":"Clin. Transl. Sci."},{"issue":"11","key":"10.1016\/j.drup.2021.100794_bib0510","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.29540","article-title":"Delirium in older patients with COVID-19 presenting to the emergency department","volume":"3","author":"Kennedy","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.drup.2021.100794_bib0515","series-title":"Summary of Product Characteristics","author":"KEVZARA (Sarilumab)","year":"2017"},{"issue":"7","key":"10.1016\/j.drup.2021.100794_bib0520","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1002\/jmv.26918","article-title":"Healthcare disparities among anticoagulation therapies for severe COVID-19 patients in the multi-site VIRUS registry","volume":"93","author":"Kirkup","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.drup.2021.100794_bib0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104502","article-title":"From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses","volume":"85","author":"Kirtipal","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.drup.2021.100794_bib0530","first-page":"1","article-title":"Early convalescent plasma for high-risk outpatients with Covid-19","author":"Korley","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0535","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13054-020-02882-x","article-title":"COVID-19: ICU delirium management during SARS-CoV-2 pandemic","volume":"24","author":"Kotfis","year":"2020","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0540","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/ph14010071","article-title":"COVID-19\u2014the potential beneficial therapeutic effects of spironolactone during SARS-CoV-2 infection","volume":"14","author":"Kotfis","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.drup.2021.100794_bib0545","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.amjcard.2020.08.004","article-title":"Meta-analysis of effect of statins in patients with COVID-19","volume":"134","author":"Kow","year":"2020","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.drup.2021.100794_bib0550","first-page":"CD013825","article-title":"SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19","volume":"9","author":"Kreuzberger","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.drup.2021.100794_bib0555","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1016\/S2665-9913(21)00216-2","article-title":"Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis","volume":"3","author":"Kyriazopoulou","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"10.1016\/j.drup.2021.100794_bib0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9061917","article-title":"COVID-19: the potential treatment of pulmonary fibrosis associated with SARS-CoV-2 infection","volume":"9","author":"Lechowicz","year":"2020","journal-title":"J. Clin. Med."},{"issue":"22","key":"10.1016\/j.drup.2021.100794_bib0565","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2020.22760","article-title":"Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial","volume":"324","author":"Lenze","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.drup.2021.100794_bib0570","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S2213-2600(21)00099-0","article-title":"Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Lescure","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"May","key":"10.1016\/j.drup.2021.100794_bib0575","article-title":"Sarilumab in patients admitted to hospital with severe or critical COVID-19\u202f: a randomised, double-blind, placebo- controlled phase 3 trial","volume":"9","author":"Lescure","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.drup.2021.100794_bib0580","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2014update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.drup.2021.100794_bib0585","doi-asserted-by":"crossref","first-page":"e24169","DOI":"10.1097\/MD.0000000000024169","article-title":"Efficacy and safety of Reyanning mixture combined with conventional Western medicine for treating COVID-19","volume":"100","author":"Li","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.drup.2021.100794_bib0590","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Lim","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.drup.2021.100794_bib0595","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.arteri.2020.06.003","article-title":"Estatinas en COVID-19: \u00bfexiste alg\u00fan fundamento?","volume":"32","author":"Lima Mart\u00ednez","year":"2020","journal-title":"Cl\u00ednica e Investig en Arterioscler"},{"issue":"33","key":"10.1016\/j.drup.2021.100794_bib0600","doi-asserted-by":"crossref","first-page":"e21614","DOI":"10.1097\/MD.0000000000021614","article-title":"Efficacy and safety of Lianhua Qingwen in the treatment of patients with moderate COVID-19 infection","volume":"99","author":"Liu","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0605","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCULATIONAHA.120.047549","article-title":"Li H. The science underlying COVID-19: implications for the cardiovascular system","volume":"142","author":"Liu","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-05763-8","article-title":"Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy","volume":"9","author":"Logue","year":"2018","journal-title":"Nat. Commun."},{"issue":"July","key":"10.1016\/j.drup.2021.100794_bib0615","article-title":"Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant","author":"Lopez Bernal","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.drup.2021.100794_bib0620","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/art.34329","article-title":"The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-\u03b3 and interleukin-17 production by human CD4+ T cells","volume":"64","author":"Maeshima","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.drup.2021.100794_bib0625","doi-asserted-by":"crossref","first-page":"n2697","DOI":"10.1136\/bmj.n2697","article-title":"Covid-19: UK becomes first country to authorise antiviral molnupiravir","volume":"375","author":"Mahase","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.drup.2021.100794_bib0630","doi-asserted-by":"crossref","first-page":"n2713","DOI":"10.1136\/bmj.n2713","article-title":"Covid-19: Pfizer\u2019s paxlovid is 89% effective in patients at risk of serious illness, company reports","volume":"375","author":"Mahase","year":"2021","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.drup.2021.100794_bib0635","doi-asserted-by":"crossref","first-page":"e742","DOI":"10.1093\/cid\/ciaa1445","article-title":"Decreased mortality in coronavirus disease 2019 patients treated with tocilizumab: a rapid systematic review and meta-analysis of observational studies","volume":"72","author":"Malgie","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"September","key":"10.1016\/j.drup.2021.100794_bib0640","article-title":"Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial","author":"Marconi","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.drup.2021.100794_bib0645","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.chest.2016.11.036","article-title":"Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study","volume":"151","author":"Marik","year":"2017","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0650","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/21505594.2019.1605803","article-title":"The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections","volume":"10","author":"Mehrbod","year":"2019","journal-title":"Virulence"},{"issue":"12","key":"10.1016\/j.drup.2021.100794_bib0655","doi-asserted-by":"crossref","first-page":"e8342","DOI":"10.1371\/journal.pone.0008342","article-title":"The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor","volume":"4","author":"Minakshi","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.drup.2021.100794_bib0660","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2213-2600(20)30511-7","article-title":"Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"Monk","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"18","key":"10.1016\/j.drup.2021.100794_bib0665","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1001\/jama.2021.18295","article-title":"Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial","volume":"326","author":"Munch","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.drup.2021.100794_bib0670","series-title":"Stable Angina: Management Clinical Guideline","author":"National Institute for Health and Care Excellence","year":"2016"},{"key":"10.1016\/j.drup.2021.100794_bib0675","series-title":"Acute Coronary Syndromes NICE Guideline","author":"National Institute for Health and Care Excellence","year":"2020"},{"key":"10.1016\/j.drup.2021.100794_bib0680","series-title":"Atrial Fibrillation: Diagnosis and Management NICE Guideline","author":"National Institute for Health and Care Excellence","year":"2021"},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0685","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/s12879-021-06104-9","article-title":"Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients","volume":"21","author":"Okumu\u015f","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.drup.2021.100794_bib0690","series-title":"Therapeutics and COVID-19: Living Guideline","author":"Organization","year":"2021"},{"issue":"5","key":"10.1016\/j.drup.2021.100794_bib0695","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02428-20","article-title":"Human safety, tolerability, and pharmacokinetics of molnupiravir, a novel broad-spectrum oral antiviral agent with activity against SARS-CoV-2","volume":"65","author":"Painter","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"04","key":"10.1016\/j.drup.2021.100794_bib0700","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0041-1726034","article-title":"Iacoviello L. Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis","volume":"47","author":"Parisi","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.drup.2021.100794_bib0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100774","article-title":"Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients","volume":"33","author":"Pawlowski","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.drup.2021.100794_bib0710","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0715","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s41231-021-00082-5","article-title":"Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients","volume":"6","author":"Peymani","year":"2021","journal-title":"Transl. Med. Commun."},{"key":"10.1016\/j.drup.2021.100794_bib0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109765","article-title":"Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19","volume":"140","author":"Pindiprolu","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"11","key":"10.1016\/j.drup.2021.100794_bib0725","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1152\/physiolgenomics.00089.2020","article-title":"The COVID-19 pandemic: a global health crisis","volume":"52","author":"Pollard","year":"2020","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.drup.2021.100794_bib0730","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fnut.2014.00014","article-title":"Zinc is an antioxidant and anti-inflammatory agent: its role in human health","volume":"1","author":"Prasad","year":"2014","journal-title":"Front. Nutr."},{"issue":"3","key":"10.1016\/j.drup.2021.100794_bib0735","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12288-021-01417-w","article-title":"Efficacy and safety of convalescent plasma for COVID-19: a systematic review and meta-analysis","volume":"37","author":"Prasad","year":"2021","journal-title":"Indian J. Hematol. Blood Transfus."},{"issue":"3","key":"10.1016\/j.drup.2021.100794_bib0740","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S2213-2600(20)30552-X","article-title":"Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study","volume":"9","author":"Pun","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"7","key":"10.1016\/j.drup.2021.100794_bib0745","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S2213-2600(21)00160-0","article-title":"Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial","volume":"9","author":"Ramakrishnan","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.drup.2021.100794_bib0750","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1590\/1516-4446-2017-2393","article-title":"Potential antidepressant effect of amantadine: a review of preclinical studies and clinical trials","volume":"40","author":"Raupp-Barcaro","year":"2018","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"4","key":"10.1016\/j.drup.2021.100794_bib0755","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1590\/1516-4446-2017-2393","article-title":"Potential antidepressant effect of amantadine: a review of preclinical studies and clinical trials","volume":"40","author":"Raupp-Barcaro","year":"2018","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.drup.2021.100794_bib0760","doi-asserted-by":"crossref","first-page":"343","DOI":"10.18433\/jpps32105","article-title":"Evaluation of ivermectin as a potential treatment for mild to moderate COVID-19: a double-blind randomized placebo controlled trial in Eastern India","volume":"24","author":"Ravikirti","year":"2021","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.drup.2021.100794_bib0765","doi-asserted-by":"crossref","first-page":"102189","DOI":"10.1016\/j.dsx.2021.102189","article-title":"Vitamin D supplementation and COVID-19 treatment: a systematic review and meta-analysis","volume":"15","author":"Rawat","year":"2021","journal-title":"Diabetes Metab Syndr Clin Res Rev."},{"key":"10.1016\/j.drup.2021.100794_bib0770","series-title":"Aspirin in Patients Admitted to Hospital With COVID-19 (RECOVERY): a Randomised, Controlled, Open-label, Platform Trial.","author":"RECOVERY Collaborative Group","year":"2021"},{"issue":"48","key":"10.1016\/j.drup.2021.100794_bib0775","doi-asserted-by":"crossref","first-page":"e23261","DOI":"10.1097\/MD.0000000000023261","article-title":"Traditional Chinese medicine formula Xiaoqinglong decoction for cough caused by COVID-19","volume":"99","author":"Ren","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"21","key":"10.1016\/j.drup.2021.100794_bib0780","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1111\/bph.15166","article-title":"Statins: Could an old friend help in the fight against COVID-19?","volume":"177","author":"Rodrigues-Diez","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"16","key":"10.1016\/j.drup.2021.100794_bib0785","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in hospitalized patients with severe Covid-19 pneumonia","volume":"384","author":"Rosas","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2021.100794_bib0790","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13613-020-00741-0","article-title":"Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review","volume":"10","author":"Sakr","year":"2020","journal-title":"Ann. Intensive Care"},{"issue":"6","key":"10.1016\/j.drup.2021.100794_bib0795","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/00016357.2020.1787505","article-title":"Sudden onset, acute loss of taste and smell in coronavirus disease 2019 (COVID-19): a systematic review","volume":"78","author":"Samaranayake","year":"2020","journal-title":"Acta Odontol. Scand."},{"issue":"2","key":"10.1016\/j.drup.2021.100794_bib0800","article-title":"Rationales and uncertainties for aspirin use in COVID-19: a narrative review","volume":"9","author":"Sayed Ahmed","year":"2021","journal-title":"Fam. Med. Commun. Heal."},{"issue":"15","key":"10.1016\/j.drup.2021.100794_bib0805","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2146\/ajhp070449","article-title":"Tocilizumab: The first interleukin-6-receptor inhibitor","volume":"65","author":"Sebba","year":"2008","journal-title":"Am. J. Health. Syst. Pharm."},{"issue":"21","key":"10.1016\/j.drup.2021.100794_bib0810","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/jama.2020.22240","article-title":"Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial","volume":"324","author":"Self","year":"2020","journal-title":"JAMA"},{"issue":"48","key":"10.1016\/j.drup.2021.100794_bib0815","doi-asserted-by":"crossref","first-page":"e23224","DOI":"10.1097\/MD.0000000000023224","article-title":"Maxingshigan decoction for treating COVID-19","volume":"99","author":"Shao","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0820","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-019-0181-7","article-title":"SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes","volume":"5","author":"Shi","year":"2019","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.drup.2021.100794_bib0825","series-title":"Autophagy and SARS-CoV-2 Infection: a Possible Smart Targeting of the Autophagy Pathway","author":"Shojaei","year":"2020"},{"issue":"11","key":"10.1016\/j.drup.2021.100794_bib0830","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/s41591-021-01542-z","article-title":"Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors","volume":"27","author":"Shroff","year":"2021","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.drup.2021.100794_bib0835","doi-asserted-by":"crossref","DOI":"10.3390\/v13040700","article-title":"Long-COVID and Post-COVID health complications: an up-to-Date review on clinical conditions and their possible molecular mechanisms","volume":"13","author":"Silva Andrade","year":"2021","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.drup.2021.100794_bib0840","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/jac\/dkaa418","article-title":"Sofosbuvir\/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis","volume":"76","author":"Simmons","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"issue":"9","key":"10.1016\/j.drup.2021.100794_bib0845","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.mayocp.2016.05.013","article-title":"Myocarditis in clinical practice","volume":"91","author":"Sinagra","year":"2016","journal-title":"Mayo Clin. Proc."},{"issue":"4","key":"10.1016\/j.drup.2021.100794_bib0850","first-page":"641","article-title":"Remdesivir in COVID-19: a critical review of pharmacology, pre-clinical and clinical studies","volume":"14","author":"Singh","year":"2020","journal-title":"Diab. Metab. Syndr. Clin. Res. Rev."},{"issue":"10","key":"10.1016\/j.drup.2021.100794_bib0855","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s00101-019-00672-x","article-title":"[Perioperative dexamethasone]","volume":"68","author":"Sinner","year":"2019","journal-title":"Anaesthesist"},{"key":"10.1016\/j.drup.2021.100794_bib0860","series-title":"Drugs and Lactation Database (LactMed). Bethesda (MD)","author":"Sotrovimab","year":"2021"},{"issue":"11","key":"10.1016\/j.drup.2021.100794_bib0865","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial","volume":"324","author":"Spinner","year":"2020","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.drup.2021.100794_bib0870","doi-asserted-by":"crossref","first-page":"e12697","DOI":"10.15252\/emmm.202012697","article-title":"Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients","volume":"12","author":"Stebbing","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"5","key":"10.1016\/j.drup.2021.100794_bib0875","first-page":"1225","article-title":"Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)","volume":"14","author":"Subir","year":"2020","journal-title":"Diab. Metab. Syndr. Clin. Res. Rev."},{"key":"10.1016\/j.drup.2021.100794_bib0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173288","article-title":"Endoplasmic reticulum as a potential therapeutic target for covid-19 infection management?","volume":"882","author":"Sureda","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"June","key":"10.1016\/j.drup.2021.100794_bib0885","article-title":"Should we supplement zinc in COVID-19 patients? Evidence from meta-analysis","author":"Szarpak","year":"2021","journal-title":"Polish. Arch. Intern. Med."},{"key":"10.1016\/j.drup.2021.100794_bib0890","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0248-8663(00)88721-4","article-title":"Pharmacologie de l\u2019aspirine","volume":"21","author":"Tanasescu","year":"2000","journal-title":"La Rev M\u00e9decine Interne"},{"key":"10.1016\/j.drup.2021.100794_bib0895","doi-asserted-by":"crossref","first-page":"m1849","DOI":"10.1136\/bmj.m1849","article-title":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","volume":"369","author":"Tang","year":"2020","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.drup.2021.100794_bib0900","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/biof.1726","article-title":"Long-COVID syndrome-associated brain fog and chemofog: luteolin to the rescue","volume":"47","author":"Theoharides","year":"2021","journal-title":"Biofactors"},{"key":"10.1016\/j.drup.2021.100794_bib0905","article-title":"COVID-19 update: the race to therapeutic development","volume":"53","author":"Twomey","year":"2020","journal-title":"Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.drup.2021.100794_bib0910","series-title":"ClinicalTrials.gov.","author":"US National Library of Medicine","year":"2020"},{"key":"10.1016\/j.drup.2021.100794_bib0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106322","article-title":"Colchicine and SARS-CoV-2: Management of the hyperinflammatory state","volume":"178","author":"Vitiello","year":"2021","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.drup.2021.100794_bib0920","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/BJ20120150","article-title":"Ivermectin is a specific inhibitor of importin \u03b1\/\u03b2-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus","volume":"443","author":"Wagstaff","year":"2012","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.drup.2021.100794_bib0925","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/crj.12646","article-title":"Efficacy of zinc given as an adjunct to the treatment of severe pneumonia: A meta-analysis of randomized, double-blind and placebo-controlled trials","volume":"12","author":"Wang","year":"2018","journal-title":"Clin. Respir. J."},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0930","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5582\/bst.2020.01030","article-title":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment","volume":"14","author":"Wang","year":"2020","journal-title":"Biosci. Trends"},{"issue":"September","key":"10.1016\/j.drup.2021.100794_bib0935","article-title":"Treatment of coronavirus disease 2019 patients with prolonged postsymptomatic viral shedding with leflunomide: a single-center randomized controlled clinical trial","author":"Wang","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2021.100794_bib0940","series-title":"Outpatients With Covid-19","article-title":"REGN-COV2, a neutralizing antibody cocktail","author":"Weinreich","year":"2021"},{"key":"10.1016\/j.drup.2021.100794_bib0945","series-title":"Weekly Epidemilogical Update on COVID-19-23 November","author":"World Health Organization","year":"2021"},{"issue":"1","key":"10.1016\/j.drup.2021.100794_bib0950","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1080\/22221751.2021.1996210","article-title":"Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern","volume":"10","author":"Yue","year":"2021","journal-title":"Emerg. Microbes Infect."},{"issue":"June","key":"10.1016\/j.drup.2021.100794_bib0955","article-title":"The mechanisms of action of Ivermectin against SARS-CoV-2: an evidence-based clinical review article","author":"Zaidi","year":"2021","journal-title":"J Antibiot (Tokyo)"},{"issue":"June","key":"10.1016\/j.drup.2021.100794_bib0960","article-title":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19","author":"Zhang","year":"2020","journal-title":"Cell Metab."},{"issue":"20","key":"10.1016\/j.drup.2021.100794_bib0965","doi-asserted-by":"crossref","first-page":"e25653","DOI":"10.1097\/MD.0000000000025653","article-title":"Efficacy and safety of Xuanfei Baidu granules for treating COVID-19","volume":"100","author":"Zhao","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.drup.2021.100794_bib0970","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijid.2020.07.053","article-title":"SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: a randomized, open-label, parallel-group trial","volume":"99","author":"Zheng","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"46","key":"10.1016\/j.drup.2021.100794_bib0975","doi-asserted-by":"crossref","first-page":"e22962","DOI":"10.1097\/MD.0000000000022962","article-title":"Efficacy and safety of xiyanping for COVID-2019","volume":"99","author":"Zhou","year":"2020","journal-title":"Medicine (Baltimore)"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764621000546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764621000546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:00:30Z","timestamp":1761282030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764621000546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":195,"alternative-id":["S1368764621000546"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2021.100794","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2021.100794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100794"}}